Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART II

William T. Lowrance(American Urological Association), Michael S. Cookson(University of Oklahoma Health Sciences Center), Rodney H. Breau(University of Ottawa), Tony Crispino, Anthony L. Zietman(Harvard University), Roger Chou(Brown University), Alicia K. Morgans(Dana-Farber Cancer Institute), Adam S. Kibel(Brigham and Women's Hospital), William Oh(Eunice Kennedy Shriver National Institute of Child Health and Human Development), Brian F. Chapin(The University of Texas MD Anderson Cancer Center), Robert Dreicer(University of Virginia), David F. Jarrard(University of Wisconsin System), Matthew J. Resnick(Vanderbilt University Medical Center), Todd M. Morgan(University of Michigan)
The Journal of Urology
September 22, 2020
10.1097/ju.0000000000001376
Cited by 126

Related Papers

What low back pain is and why we need to pay attention
|The Lancet|2018|4.7k
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
|The Lancet|2016|3.7k
Management of Postoperative Pain: A Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council
|Journal of Pain|2016|3.2k
Whole-Body Hypothermia for Neonates with Hypoxic–Ischemic Encephalopathy
|New England Journal of Medicine|2005|2.8k
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
|New England Journal of Medicine|2015|2.8k